Health Care/Hospital

DarwinHealth Scientists Publish Foundational Research Identifying Regulatory Mechanisms Controlling Cancer Cell States and Drug Response

NEW YORK, Jan. 12, 2021 /PRNewswire/ -- DarwinHealth, Inc., a New York-based biotechnology and cancer drug discovery company announces the January 11, 2021 online publication in Cell of a landmark paper, "A Modular Master Regulator Landscape Controls Cancer Transcriptional Identity,"[1,2] in whic...

2021-01-12 08:21 2341

MedSkin Solutions Dr. Suwelack AG Receives FDA 510(k) Clearance for MatriDerm® - Its Three-Dimensional Acellular Collagen Elastin Dermal Matrix Portfolio

MedSkin Solutions Dr. Suwelack AG announces receiving FDA 510(k) clearance for its flagship Med Care product portfolio MatriDerm®. HAMBURG, Germany, Jan. 12, 2021 /PRNewswire/ -- MatriDerm® is a single-use three-dimensional acellular dermal matrix composed of bovine collagen fibers and bovine el...

2021-01-12 04:38 1631

Regent Pacific Announces Key Research Findings On FORTACIN™

HONG KONG, Jan. 11, 2021 /PRNewswire/ -- Regent Pacific Group Limited ("Regent Pacific" or the "Company" and together with its subsidiaries, the "Group"; stock code: 0575.HK), a specialist healthcare, wellness and life sciences investment group is pleased to announce several key findings on the w...

2021-01-11 23:36 10093

Announcing Calyx: Advancing Clinical Research Through Technology-Enabled Services

Formerly Parexel Informatics, Calyx is a market-leading Medical Imaging, eClinical, and Regulatory solutions provider NOTTINGHAM, England, Jan. 11, 2021 /PRNewswire/ -- Calyx, a leading provider of Medical Imaging, eClinical, and Regulatory solutions and services to solve complex challenges in c...

2021-01-11 19:05 2233

Amazfit Introduces the Ultra-fashionable Amazfit GTR 2e and GTS 2e Smartwatches with Cutting-edge Health and Fitness Features

LAS VEGAS, Jan. 11, 2021 /PRNewswire/ -- Amazfit, a global brand in the wearables market, unveiled the Amazfit GTR 2e and GTS 2e smartwatches at this year's all-digital CES. Featuring the latest fitness tracking features along with an ultra-thin and fashionable design, the two latest additions to...

2021-01-11 18:30 3775

Airnov Made Its Debut at CPhI China

SHANGHAI, Jan. 11 2021 /PRNewswire/ -- Airnov Healthcare Packaging made its debut successfully at the CPhI China 2020 at Shanghai New International Expo Center on December 16-18. The global leader in healthcare packaging attended the event with its latest innovations including HAT® IN desiccant v...

2021-01-11 16:26 2692

Polygiene acquisition expands sustainable offering

STOCKHOLM, Jan. 11, 2021 /PRNewswire/ -- Sweden-based company Polygiene buys British Addmaster Holdings Limited, making it a comprehensive supplier of antimicrobial solutions for both soft and hard surfaces. On one of the last days of the year, an extraordinary general meeting voted in favor of ...

2021-01-11 16:21 7117

Pivotal phase III clinical trial IND submission of the original innovative anticancer drug Chiauranib for the treatment of small cell lung cancer was accepted by the Center of Drug Evaluation of the NMPA.

SHENZHEN, China, Jan. 11, 2021 /PRNewswire/ -- On January 8, 2021, Shenzhen Chipscreen Biosciences Co., Ltd. (Chipscreen Biosciences, Stock Symbol: 688321.SH) submitted its pivotal phase III clinical trial application (IND) of national class I innovative drug Chiauranib to NMPA, for the treatment...

2021-01-11 11:33 3081

HRH Prince Mohammed bin Salman announces THE LINE at NEOM

A revolution in urban living - Free of cars and streets, residents will have nature and all daily needs within a five-minute walk - To create 380,000 jobs of the future and contribute SAR 180bn ($48bn) to GDP by 2030 - 170km linear development of hyper-connected AI-enabled communities powered ...

2021-01-11 08:32 5048

Antengene to Present at the 39th Annual J.P. Morgan Healthcare Conference

SHANGHAI and SAN FRANCISCO, Jan. 11, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in class therapeutics in hematology an...

2021-01-11 07:26 2133

Standigm and SK Chemicals Repurpose FDA-approved Drug into Rheumatoid Arthritis Candidate and Apply for Patent through their Open Innovation Partnership

SEOUL, South Korea, Jan. 11, 2021 /PRNewswire/ -- Standigm Inc.("Standigm"), an AI-based drug discovery company and SK Chemicals Co., Ltd.("SK Chemicals"), a life science and green chemicals company, announced that they had successfully found a new arthritis indication for an FDA-approved drug an...

2021-01-11 07:00 1983

Kintor's Proxalutamide (GT0918) COVID-19 Clinical Trial Shows Positive Preliminary Results in Treatment of Female Patients

SUZHOU, China, Jan. 10, 2021 /PRNewswire/ -- Kintor Pharmaceutical Limited (HKEX: 9939) is pleased to update the preliminary analysis of the clinical trial of Proxalutamide for the treatment of COVID-19 patients. The investigator initiated trial conducted by Dr.Andy Goren and Dr. Flávio Adsuara C...

2021-01-10 16:55 3838
1 ... 546547548549550